Temporary Vascular Occlusion Clamp (TVOC)
Award Notice Posted
- Solicitation number
- FA238424CB015
- Agency
-
Air Force Research Laboratory
Air Force Materiel Command, Department of Defense
- Awarded
- to Amsel Medical Corporation
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- FA238424CB015 Federal contract award
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- PSC
- Not on record
- Place of performance
- Cambridge, Massachusetts 02141, United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The Department of the Air Force Materiel Command Research Laboratory, also known as the Air Force Research Laboratory, awarded a $7,453,975.00 cost-plus-fixed-fee SBIR Phase III contract to Amsel Medical Corporation in Cambridge, Massachusetts. The contract provides for the development of an FDA-approved temporary vascular occlusion clamp. The work is expected to be completed by March 30, 2027.
Notice text
Amsel Medical Corporation, Cambridge, MA, was awarded a $7,453,975.00 cost-plus--fixed-fee SBIR Phase III contract. This contract provides for the development of an FDA-approved temporary vacsular occlusion clamp. Work will be performed in Cambridge, Massachusetts, and is expected to be completed 30 March 2027.
Awarded contract FA238424CB015 to AMSEL MEDICAL CORPORATION for 7453975.00 on 2024-09-30.
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity